LPCN - Lipocine Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Salt Lake City,
United States
Type: Equity
LPCN price evolution
LPCN
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4.77 | $3.15 | $2.4 | $4.98 |
| Short term investments | $24.1 | $29.38 | $31.86 | $32.41 |
| Net receivables | $0.04 | $0.08 | $0.04 | $0.08 |
| Inventory | ||||
| Total current assets | $30.61 | $34.14 | $36.11 | $38.08 |
| Long term investments | ||||
| Property, plant & equipment | $0.13 | $0.13 | $0.04 | $0.04 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $3.41 | $3.41 | $3.31 | $4.11 |
| Total investments | $24.1 | $29.38 | $31.86 | $32.41 |
| Total assets | $34.02 | $37.54 | $39.42 | $42.19 |
| Current liabilities | ||||
| Accounts payable | $0.8 | $0.6 | $0.63 | $0.81 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1.93 | $1.68 | $1.51 | $1.71 |
| Long term debt | ||||
| Total noncurrent liabilities | $0.13 | $0.23 | $0.26 | $0.59 |
| Total debt | ||||
| Total liabilities | $2.06 | $1.91 | $1.78 | $2.3 |
| Shareholders' equity | ||||
| Retained earnings | -$187.3 | -$183.43 | -$181.2 | -$178.79 |
| Other shareholder equity | $0 | -$0.02 | -$0.08 | -$0.08 |
| Total shareholder equity | $31.96 | $35.63 | $37.65 | $39.89 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3.15 | $2.95 | $24.22 | $14.73 |
| Short term investments | $29.38 | $41.67 | $0.45 | $4.34 |
| Net receivables | $0.08 | $0.25 | $0 | $0.02 |
| Inventory | ||||
| Total current assets | $34.14 | $46.38 | $25.33 | $19.63 |
| Long term investments | $2.02 | |||
| Property, plant & equipment | $0.13 | $0.01 | $0 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $3.41 | $6.1 | $0.02 | $0.03 |
| Total investments | $29.38 | $43.69 | $0.45 | $4.34 |
| Total assets | $37.54 | $52.48 | $25.35 | $19.66 |
| Current liabilities | ||||
| Accounts payable | $0.6 | $1.29 | $1.6 | $1.18 |
| Deferred revenue | ||||
| Short long term debt | $2.31 | $3.33 | $3.33 | |
| Total current liabilities | $1.68 | $5.62 | $6.58 | $4.96 |
| Long term debt | $2.26 | $3.81 | ||
| Total noncurrent liabilities | $0.23 | $1.3 | $3.43 | $8.41 |
| Total debt | $2.31 | $5.59 | $7.15 | |
| Total liabilities | $1.91 | $6.91 | $10.01 | $13.37 |
| Shareholders' equity | ||||
| Retained earnings | -$183.43 | -$172.67 | -$172.03 | -$151.07 |
| Other shareholder equity | -$0.02 | -$0.02 | -$0.04 | -$0 |
| Total shareholder equity | $35.63 | $45.57 | $15.34 | $6.29 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.05 | $0.5 | ||
| Cost of revenue | ||||
| Gross Profit | $0.05 | $0.5 | ||
| Operating activities | ||||
| Research & development | $3.11 | $1.67 | $2.1 | $2.9 |
| Selling, general & administrative | $1.29 | $0.89 | $0.8 | $1.13 |
| Total operating expenses | $4.39 | $2.56 | $2.9 | $4.03 |
| Operating income | -$4.34 | -$2.56 | -$2.9 | -$3.53 |
| Income from continuing operations | ||||
| EBIT | -$3.87 | -$2.23 | -$2.41 | -$2.62 |
| Income tax expense | $0 | $0 | ||
| Interest expense | $0.01 | |||
| Net income | ||||
| Net income | -$3.87 | -$2.23 | -$2.41 | -$2.63 |
| Income (for common shares) | -$3.87 | -$2.23 | -$2.41 | -$2.63 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.5 | $16.14 | $0.16 | |
| Cost of revenue | ||||
| Gross Profit | $0.5 | $16.14 | $0.16 | |
| Operating activities | ||||
| Research & development | $8.56 | $7.67 | $9.75 | $7.47 |
| Selling, general & administrative | $4.06 | $5.33 | $8.25 | $5.6 |
| Total operating expenses | $12.62 | $13 | $18 | $13.07 |
| Operating income | -$12.12 | $3.15 | -$18 | -$12.9 |
| Income from continuing operations | ||||
| EBIT | -$10.73 | -$0.43 | -$20.58 | -$13.01 |
| Income tax expense | $0 | $0 | $0 | $0 |
| Interest expense | $0.03 | $0.2 | $0.39 | |
| Net income | ||||
| Net income | -$10.76 | -$0.63 | -$20.96 | -$13.01 |
| Income (for common shares) | -$10.76 | -$0.63 | -$20.96 | -$13.01 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$3.87 | -$2.23 | -$2.41 | -$2.63 |
| Operating activities | ||||
| Depreciation | $0 | $0 | $0 | $0 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.18 | $0.17 | $0.16 | $0.14 |
| Total cash flows from operations | -$3.93 | -$1.84 | -$3.2 | -$3.05 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0.1 | -$0.01 | |
| Investments | $5.56 | $2.69 | $0.61 | $3.8 |
| Total cash flows from investing | $5.55 | $2.6 | $0.61 | $3.79 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.01 | $0 | -$0.01 | |
| Net borrowings | -$1.48 | |||
| Total cash flows from financing | -$0.01 | -$0.01 | $0 | -$1.49 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1.62 | $0.75 | -$2.58 | -$0.75 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$10.76 | -$0.63 | -$20.96 | -$13.01 |
| Operating activities | ||||
| Depreciation | $0.01 | $0 | $0 | $0.02 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.64 | $0.6 | $1.37 | $1.04 |
| Total cash flows from operations | -$11.97 | -$4.41 | -$15.3 | -$11.67 |
| Investing activities | ||||
| Capital expenditures | -$0.13 | -$0.01 | ||
| Investments | $14.43 | -$43.77 | $3.89 | $3 |
| Total cash flows from investing | $14.29 | -$43.78 | $3.89 | $3 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.19 | $30.26 | $22.33 | $13.65 |
| Net borrowings | -$2.32 | -$3.33 | -$1.43 | -$3.33 |
| Total cash flows from financing | -$2.13 | $26.92 | $20.9 | $10.32 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.2 | -$21.27 | $9.49 | $1.65 |
News
Fundamentals
| Market cap | $23.43M |
|---|---|
| Enterprise value | $18.66M |
| Shares outstanding | 5.21M |
| Revenue | $554.99K |
|---|---|
| EBITDA | -$11.12M |
| EBIT | -$11.13M |
| Net Income | -$11.14M |
| Revenue Q/Q | InfinityT% |
| Revenue Y/Y | -96.56% |
| P/E ratio | -2.10 |
|---|---|
| EV/Sales | 33.62 |
| EV/EBITDA | -1.68 |
| EV/EBIT | -1.68 |
| P/S ratio | 42.22 |
| P/B ratio | 0.73 |
| Book/Share | 6.14 |
| Cash/Share | 0.92 |
| EPS | -$2.14 |
|---|---|
| ROA | -29.09% |
| ROE | -30.71% |
| Debt/Equity | 0.05 |
|---|---|
| Net debt/EBITDA | 0.24 |
| Current ratio | 15.86 |
| Quick ratio | 15.86 |